MED PATIENTS INFORMED CONSENT House SponsorsRep. Robyn Gabel, Kelly M. Cassidy, Will Guzzardi and Jay Hoffman 1/13/2021HouseSession Sine Die 410 ILCS 50/3from Ch. 111 1/2, par. 5403 Amends the Medical Patient Rights Act. Provides that a patient or representative of the patient must give informed consent, or informed permission in the case of an infant, for biochemical testing for controlled substances unless there is a medical emergency and there is inadequate time to obtain consent. Describes the specific information that health care providers to supply to a patient, or a patient's representative, before informed consent can be given. Effective immediately. 2/15/2019HouseFiled with the Clerk by Rep. Robyn Gabel 2/15/2019HouseFirst Reading 2/15/2019HouseReferred to Rules Committee 2/21/2019HouseAdded Co-Sponsor Rep. Kelly M. Cassidy 3/5/2019HouseAssigned to Health Care Licenses Committee 3/19/2019HouseAdded Co-Sponsor Rep. Will Guzzardi 3/21/2019HouseAdded Co-Sponsor Rep. Jay Hoffman 3/27/2019HouseDo Pass / Short Debate Health Care Licenses Committee; 009-005-000 3/29/2019HousePlaced on Calendar 2nd Reading - Short Debate 4/4/2019HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Robyn Gabel 4/4/2019HouseHouse Floor Amendment No. 1 Referred to Rules Committee 4/10/2019HouseSecond Reading - Short Debate 4/10/2019HouseHeld on Calendar Order of Second Reading - Short Debate 4/12/2019HouseRule 19(a) / Re-referred to Rules Committee 1/13/2021HouseSession Sine Die